Holen Sie sich die Stockscreener-App
36.76
2.83%
-1.07
Handel nachbörslich:
36.44
-0.32
-0.87%
Schlusskurs vom Vortag:
$37.83
Offen:
$37.51
24-Stunden-Volumen:
1.82M
Relative Volume:
0.71
Marktkapitalisierung:
$4.35B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$251.00M
KGV:
18.62
EPS:
1.9744
Netto-Cashflow:
$-193.86M
1W Leistung:
-6.94%
1M Leistung:
+13.04%
6M Leistung:
+20.56%
1J Leistung:
+232.07%
1-Tages-Spanne:
$36.62
$37.90
1-Wochen-Bereich:
$36.62
$39.70
52-Wochen-Spanne:
$11.04
$41.00
Indivior Pharmaceuticals Inc Stock (INDV) Company Profile
Firmenname
Indivior Pharmaceuticals Inc
Sektor
Telefon
804-379-1090
Adresse
10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD
Compare INDV vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Pharmaceuticals Inc
|
36.76 | 4.47B | 1.29B | 251.00M | -193.86M | 1.9744 |
TAK
Takeda Pharmaceutical Co Adr
|
16.61 | 52.55B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.29 | 41.12B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.96 | 39.50B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
74.22 | 31.64B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.58 | 24.44B | 3.17B | 1.29B | 1.01B | 27.09 |
Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-22 | Fortgesetzt | Jefferies | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Indivior Pharmaceuticals Inc Aktie (INDV) Neueste Nachrichten
Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership - TipRanks
Madison Avenue entities (INDV) disclose 4.32M-share, ~3.5% stake - Stock Titan
Bears are losing control over Indivior Pharmaceuticals Inc. (INDV), here's why it's a 'buy' now - MSN
Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now - Yahoo Finance
Indivior’s CEO lines up June investor meetings in New York and Miami - Stock Titan
Naloxone Market to See Booming Growth 2026-2033 | EMERGENT, Indivior PLC, Akorn, Inc - openPR.com
Indivior launches $175M accelerated share buyback - MSN
Fuller & Thaler Asset Mgmt (NASDAQ: INDV) holds 4.53M shares, 3.72% - Stock Titan
Number of shareholders of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally - AOL.com
Net income before discontinued operations of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Working capital per share of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – TRADEGATE:E7P - TradingView
BDTX Shares Gain 11% in a Week: Here's What You Should Know - TradingView
Indivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should know - MSN
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Strong Recent Share Price Run - Yahoo Finance
Indivior Pharmaceuticals Inc. (INDV) Q1 earnings and revenues beat estimates - MSN
Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After Its 261% One-Year Surge? - Sahm
Indivior Pharmaceuticals Inc. (INDV) is a great momentum stock: Should you buy? - MSN
BEAM's Q1 Loss Wider Than Expected, Revenues Beat Estimates - TradingView
Zacks.com featured highlights include The Vita Coco Company, Indivior Pharmaceuticals and Marathon Petroleum - sharewise.com
Wall Street analysts predict a 27.76% upside in Indivior Pharmaceuticals Inc. (INDV): Here's what you should know - MSN
INDV Stock Price, Quote & Chart | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations - Quantisnow
Why Indivior Pharmaceuticals (INDV) Is Up 9.8% After Raising 2026 Revenue Guidance And Earnings - Sahm
Indivior Pharmaceuticals Inc. (INDV) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Indivior Pharmaceuticals Inc. (INDV) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Here's why momentum in Indivior Pharmaceuticals Inc. (INDV) should keep going - MSN
Wall Street Analysts Predict a 27.76% Upside in Indivior Pharmaceuticals Inc. (INDV): Here's What You Should Know - Yahoo Finance
Best Momentum Stock to Buy for May 5th - Yahoo Finance
Indivior Announces $175 Million Accelerated Share Repurchase Agreement Under Existing Authorization - Minichart
Indivior Announces $175 Million Accelerated Share Repurchase - TipRanks
Indivior starts $175M buyback with 3.7M shares due upfront - Stock Titan
Indivior enters $175M accelerated share repurchase, receives 3.72M initial shares - TradingView
Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum - The Globe and Mail
Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After A 214% One-Year Surge? - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Bausch + Lomb Corporation (BLCO) and Indivior (INDV) - The Globe and Mail
Indivior Pharmaceuticals Q1 2026 Deep Dive: EPS Beats by 43.3%, Revenue Up 19% - AlphaStreet
Indivior (INDV) Q1 2026 Earnings Transcript - AOL.com
Finanzdaten der Indivior Pharmaceuticals Inc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.23%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):